Geneva Partners’s Lam Research LRCX Stock Holding History

Geneva Partners’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.93M	Sell	11,968 -3,315	-22%	-$1.04M	1.18%	29
2026 Q2	$6.62M	Buy	15,283 +2,885	+23%	+$876K	1.77%	26
2026 Q1	$2.65M	Buy	+12,398	New	+$2.77M	1.27%	27
2024 Q3	–	Sell	-43,630	Closed	-$4.65M	–	77
2024 Q2	$4.65M	Buy	43,630 +28,440	+187%	+$2.73M	1.91%	21
2024 Q1	$1.48M	Buy	15,190 +3,190	+27%	+$281K	0.65%	43
2023 Q4	$940K	Sell	12,000 -10,240	-46%	-$698K	0.52%	45
2023 Q3	$1.39M	Buy	22,240 +9,050	+69%	+$595K	0.93%	33
2023 Q2	$848K	Buy	+13,190	New	+$743K	0.55%	42
2020 Q1	–	Sell	-16,100	Closed	-$471K	–	69
2019 Q4	$471K	Buy	+16,100	New	+$428K	0.33%	57

Other funds holding LRCX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Geneva Partners's LRCX Position: Q3 2026 in Review

Geneva Partners reduced its Lam Research (LRCX) stake by 22% in Q3 2026, selling an estimated $1.04M and leaving 11,968 shares worth $3.93M. The position accounts for 1.18% of the portfolio, ranked #29.

Geneva Partners first reported a position in LRCX in Q4 2019 and has held it in 9 quarters since. The position peaked at $6.62M in Q2 2026. 1,700 funds tracked by Wall St. Rank hold LRCX as of Q3 2026.

Geneva Partners held 11,968 shares of Lam Research worth $3.93M as of Q3 2026.
Geneva Partners sold 3,315 Lam Research shares in Q3 2026, an estimated $1.04M.
Lam Research made up 1.18% of Geneva Partners's portfolio in Q3 2026, its #29 holding.
Geneva Partners first reported a position in Lam Research in Q4 2019 and has held it in 9 quarters since.
Geneva Partners's Lam Research position peaked at $6.62M in Q2 2026.
1,700 funds tracked by Wall St. Rank held Lam Research as of Q3 2026.

Based on Geneva Partners's 13F filing for Q3 2026, filed 26 Oct 2026.